SurModics And Nexeon MedSystems To Collaborate On Development Of Novel Stent System For Renal Artery Disease

SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Nexeon MedSystems, Inc., a developer of medical devices for the treatment of cardiovascular and peripheral vascular disease, announced today that the companies have signed a licensing agreement to collaborate on development of a novel stent system for the treatment of renal artery disease.

More: continued here

Filed under: Cardiovascular on February 2nd, 2009